/Thermo%20Fisher%20Scientific%20Inc_%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
Thermo Fisher Scientific Inc. (TMO), headquartered in Waltham, Massachusetts, offers life sciences solutions, analytical instruments, specialty diagnostics, laboratory products, and biopharma services. Valued at $205.8 billion by market cap, the company provides a portfolio of reagents, instruments, and consumables for research, drug development, and disease diagnosis, along with laboratory products and biopharma services under brands like Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.
Shares of this leading scientific research services and products provider have underperformed the broader market over the past year. TMO has declined 1.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 23.5%. In 2025, TMO stock is up 2.4%, compared to SPX’s 4% rise on a YTD basis.